Sign In
Buy ILMN
$170.93
+8.38 (+5.16%)
At Close: Jun 03, 2026
Illumina (ILMN) Beats Q2 Earnings and Revenue Estimates
07:01pm, Thursday, 05'th Aug 2021
Illumina (ILMN) delivered earnings and revenue surprises of 37.50% and 11.26%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Illumina: Q2 Earnings Insights
06:09pm, Thursday, 05'th Aug 2021
Shares of Illumina (NASDAQ:ILMN) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 201.61% over the past year to $1.87, which beat
Drug/Biotech Stocks Q2 Earnings Due on Aug 5: REGN, MRNA, ZTS, ILMN
12:13pm, Wednesday, 04'th Aug 2021
Let us take a look at what is in store for some of the drug/biotech stocks, which are scheduled to report on Aug 5.
Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India
09:30pm, Tuesday, 03'rd Aug 2021
SAN DIEGO, Aug. 3, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) has donated $1 million in sequencing capabilities to the Molecular Diagnostic Reference Laboratory at Kasturba Hospital, in the M
3 Things About Illumina That Smart Investors Know
06:35am, Friday, 30'th Jul 2021
The company is cemented as the industry leader, but a crack is showing.
After Naming a New CFO, Is This Genetic Diagnostics Company a Buy?
06:55am, Thursday, 29'th Jul 2021
Veracyte appointed Rebecca Chambers, who boasts a wealth of financial executive experience, to the position.
Illumina to Webcast Upcoming Investor Conference
06:30pm, Wednesday, 28'th Jul 2021
SAN DIEGO--(BUSINESS WIRE)---- $ILMN #ILMN--Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: UBS Genomics 2.0 and MedTech Innova
Illumina: Not All Rests With The Grail Acquisition
12:03pm, Tuesday, 27'th Jul 2021
The commentary surrounding Illumina seems to believe its fate stems on the Grail transaction. Nothing changes materially for the company if it fails, given strengths in the core business and key wins
Illumina-Grail $8B Merger Hit By European Commission's In-Depth Investigation
12:28pm, Friday, 23'rd Jul 2021
The European Commission has opened an in-depth, three-month investigation into Illumina Inc's (NASDAQ: ILMN) planned takeover of Grail, a deal valued between $7 billion to $8 billion. Last week, t
Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase
12:49pm, Thursday, 22'nd Jul 2021
SAN DIEGO--(BUSINESS WIRE)--Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase.
EU antitrust regulators to investigate Illumina, Grail deal
12:19pm, Thursday, 22'nd Jul 2021
EU antitrust regulators opened on Thursday a full-scale investigation into U.S. life sciences company Illumina Inc's proposed buy of cancer test maker Grail Inc, worried that the deal may curb innovat
3 Reasons Why Growth Investors Shouldn't Overlook Illumina (ILMN)
01:54pm, Wednesday, 21'st Jul 2021
Illumina (ILMN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Can Illumina (ILMN) Keep the Earnings Surprise Streak Alive?
01:54pm, Tuesday, 20'th Jul 2021
Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Illumina, Grail Merger Faces Full-Scale European Probe Amid Antitrust Concerns: Reuters
11:50am, Wednesday, 14'th Jul 2021
The proposed $8 billion merger between liquid biopsy firm Grail Inc and cancer blood screening firm Illumina Inc (NASDAQ: ILMN) has met with nothing but flack since it was first announced in Septe
Is Illumina a Buy?
07:31am, Wednesday, 14'th Jul 2021
Illumina has gained almost 29% this year and could be headed higher.
